Healthcare Analytical Testing Services Market
授權報價
| Single User License | $5,950 USD |
| Enterprise License | $6,950 USD |
| Corporate User License | $8,950 USD |
完整報告名稱與涵蓋範圍
Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2026 - 2033
報告摘要
Healthcare Analytical Testing Services Market Summary
The global healthcare analytical testing services market size was valued at USD 17.0 billion in 2025 and is projected to grow from USD 18.4 billion in 2026 to USD 32.7 billion by 2033, at a CAGR of 8.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 39.2% in 2025. The healthcare analytical testing services industry is experiencing sustained growth driven by increasing pharmaceutical and biotechnology research activities, expanding biologics and biosimilars pipelines, rising outsourcing of analytical testing services, stringent global regulatory requirements, and continuous advancements in analytical technologies.
Growing investments in cell and gene therapies, antibody drug conjugates, RNA therapeutics, and personalized medicines are further increasing demand for specialized analytical capabilities across the product development lifecycle. Pharmaceutical companies are seeking faster development timelines while maintaining regulatory compliance, leading to greater adoption of outsourced testing services that offer advanced instrumentation and scientific expertise. One of the primary growth factors is the rapid expansion of biologics and other complex therapeutics. Biologics require extensive characterization, impurity profiling, stability assessment, bioanalytical studies, and comparability testing before regulatory approval.
Such products involve sophisticated molecular structures and greater manufacturing variability than conventional small-molecule drugs, creating demand for highly specialized analytical laboratories equipped with advanced chromatography, mass spectrometry, spectroscopy, and molecular biology platforms. For instance, in October 2025, Eurofins Viracor BioPharma Services commenced operations at a renovated 8,800 m² laboratory in Lenexa, Kansas, expanding specialty bioanalytical and biomarker testing capabilities for infectious diseases, oncology, autoimmune disorders, cell and gene therapies, and biologics, while adding LCMS bioanalytical capacity for both large and small molecule drug development.
In addition, the increasing outsourcing of analytical testing by pharmaceutical, biotechnology, and medical device manufacturers. Many companies prefer external analytical laboratories to gain access to specialized expertise, validated analytical methods, regulatory knowledge, and advanced instrumentation without making substantial capital investments. Outsourcing also enables manufacturers to optimize operational costs, improve laboratory efficiency, and accelerate regulatory submissions while focusing internal resources on drug discovery and manufacturing activities. The growing number of virtual biotechnology companies and small biopharmaceutical firms with limited in-house analytical infrastructure continues to strengthen demand for contract analytical testing providers across preclinical, clinical, and commercial development stages.
Global Healthcare Analytical Testing Services Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare analytical testing services market report based on type and region:
• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Medical Device Analytical Testing Services
o Extractable and Leachable
o Material Characterization
o Physical Testing
o Bioburden Testing
o Sterility Testing
o Other Tests
• Pharmaceutical Analytical Testing Services
o Bioanalytical Testing
o Method Development and Validation
o Stability Testing
o Other Testing Services
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o UAE
o Saudi Arabia
o Kuwait
o Qatar
o Oman
目錄 Table of Contents
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis
4.1. Healthcare Analytical Testing Services Market, By Type: Segment Dashboard
4.2. Healthcare Analytical Testing Services Market, By Type: Movement Analysis
4.3. Healthcare Analytical Testing Services Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million/Billion)
4.4. Medical Device Analytical Testing Services
4.4.1. Medical Device Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.2. Extractable and Leachable
4.4.2.1. Extractable and Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.3. Material Characterization
4.4.3.1. Material Characterization Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.4. Physical Testing
4.4.4.1. Physical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.5. Bioburden Testing
4.4.5.1. Bioburden Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.6. Sterility Testing
4.4.6.1. Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.4.7. Others
4.4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5. Pharmaceutical Analytical Testing Services
4.5.1.1. Pharmaceutical Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5.2. Bioanalytical Testing
4.5.2.1. Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5.3. Method Development and Validation
4.5.3.1. Method Development and Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5.4. Stability Testing
4.5.4.1. Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5.5. Other Testing Services
4.5.5.1. Other Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2025 & 2033
5.3. North America
5.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.3.2. U.S
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Framework
5.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.3.3. Canada
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.3.4. Mexico
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4. Europe
5.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.2. UK
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.3. Germany
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.4. France
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.5. Italy
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.6. Spain
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.7. Denmark
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.8. Sweden
5.4.8.1. Key Country Dynamics
5.4.8.2. Competitive Scenario
5.4.8.3. Regulatory Framework
5.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.9. Norway
5.4.9.1. Key Country Dynamics
5.4.9.2. Competitive Scenario
5.4.9.3. Regulatory Framework
5.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5. Asia Pacific
5.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.2. Japan
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.3. China
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.4. India
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.5. Australia
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.6. Thailand
5.5.6.1. Key Country Dynamics
5.5.6.2. Competitive Scenario
5.5.6.3. Regulatory Framework
5.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5.7. South Korea
5.5.7.1. Key Country Dynamics
5.5.7.2. Competitive Scenario
5.5.7.3. Regulatory Framework
5.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.6. Latin America
5.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.6.2. Brazil
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.6.3. Argentina
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7. MEA
5.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.2. South Africa
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.3. UAE
5.7.3.1. Key Country Dynamics
5.7.3.2. Competitive Scenario
5.7.3.3. Regulatory Framework
5.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.4. Saudi Arabia
5.7.4.1. Key Country Dynamics
5.7.4.2. Competitive Scenario
5.7.4.3. Regulatory Framework
5.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.5. Kuwait
5.7.5.1. Key Country Dynamics
5.7.5.2. Competitive Scenario
5.7.5.3. Regulatory Framework
5.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.6. Qatar
5.7.6.1. Key Country Dynamics
5.7.6.2. Competitive Scenario
5.7.6.3. Regulatory Framework
5.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.7.7. Oman
5.7.7.1. Key Country Dynamics
5.7.7.2. Competitive Scenario
5.7.7.3. Regulatory Framework
5.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 6. Competitive Landscape
6.1. Key Participant Categorization
6.1.1. Market Leaders
6.1.2. Emerging Players
6.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
6.3. Company Profiles
6.3.1. Thermo Fisher Scientific, Inc.
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Service Benchmarking
6.3.1.4. Strategic Initiatives
6.3.2. ICON plc
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Service Benchmarking
6.3.2.4. Strategic Initiatives
6.3.3. LabCorp
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Service Benchmarking
6.3.3.4. Strategic Initiatives
6.3.4. Charles River Laboratories
6.3.4.1. Company Overview
6.3.4.2. Financial Performance
6.3.4.3. Service Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Syneos Health
6.3.5.1. Company Overview
6.3.5.2. Financial Performance
6.3.5.3. Service Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. SGS SA
6.3.6.1. Company Overview
6.3.6.2. Financial Performance
6.3.6.3. Service Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Eurofins Scientific
6.3.7.1. Company Overview
6.3.7.2. Financial Performance
6.3.7.3. Service Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Pace Analytical Services, LLC
6.3.8.1. Company Overview
6.3.8.2. Financial Performance
6.3.8.3. Service Benchmarking
6.3.8.4. Strategic Initiatives
6.3.9. Toxikon, Inc.
6.3.9.1. Company Overview
6.3.9.2. Financial Performance
6.3.9.3. Service Benchmarking
6.3.9.4. Strategic Initiatives
6.3.10. Intertek Group
6.3.10.1. Company Overview
6.3.10.2. Financial Performance
6.3.10.3. Service Benchmarking
6.3.10.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 4 North America Healthcare Analytical Testing Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 5 North America Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 6 U.S. Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 7 Canada Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 8 Mexico Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 9 Europe Healthcare Analytical Testing Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 10 Europe Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 11 UK Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 12 Germany Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 13 France Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 14 Italy Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 15 Spain Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 16 Denmark Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 17 Sweden Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 18 Norway Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 19 Asia Pacific Healthcare Analytical Testing Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 20 Asia Pacific Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 21 Japan Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 22 China Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 23 India Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 24 Australia Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 25 Thailand Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 26 South Korea Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 27 Latin America Healthcare Analytical Testing Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 28 Latin America Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 29 Brazil Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 30 Argentina Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 31 Middle East & Africa Healthcare Analytical Testing Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million/Billion)
Table 32 Middle East & Africa Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 33 South Africa Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 34 Saudi Arabia Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 35 UAE Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 36 Kuwait Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 37 Oman Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
Table 38 Qatar Healthcare Analytical Testing Services Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million/Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2025 (USD Billion)
Fig. 15 Ancillary market outlook, 2025 (USD Billion)
Fig. 16 Healthcare Analytical Testing Services Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Healthcare Analytical Testing Services Market: Type outlook and key takeaways
Fig. 20 Healthcare Analytical Testing Services Market: Type movement analysis
Fig. 21 Medical Device Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 22 Extractable and Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 23 Material Characterization Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 24 Physical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 25 Bioburden Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 26 Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 27 Other Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 28 Pharmaceutical Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 29 Bioanalytical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 30 Method Development and Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 31 Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 32 Other Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 33 Regional Marketplace: Key Takeaways
Fig. 34 North America Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 35 Key country dynamics
Fig. 36 U.S. Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 37 Key country dynamics
Fig. 38 Canada Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 39 Key country dynamics
Fig. 40 Mexico Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 41 Europe Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 42 Key country dynamics
Fig. 43 UK Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 44 Key country dynamics
Fig. 45 Germany Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 46 Key country dynamics
Fig. 47 France Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 48 Key country dynamics
Fig. 49 Italy Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 50 Key country dynamics
Fig. 51 Spain Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 52 Key country dynamics
Fig. 53 Denmark Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 54 Key country dynamics
Fig. 55 Sweden Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 56 Key country dynamics
Fig. 57 Norway Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 58 Asia Pacific Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 59 Key country dynamics
Fig. 60 Japan Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 61 Key country dynamics
Fig. 62 China Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 63 Key country dynamics
Fig. 64 India Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 65 Key country dynamics
Fig. 66 Australia Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 67 Key country dynamics
Fig. 68 Thailand Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 69 Key country dynamics
Fig. 70 South Korea Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 71 Latin America Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 72 Key country dynamics
Fig. 73 Brazil Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 74 Key country dynamics
Fig. 75 Argentina Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 76 Middle East and Africa Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 77 Key country dynamics
Fig. 78 South Africa Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 79 Key country dynamics
Fig. 80 UAE Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 81 Key country dynamics
Fig. 82 Saudi Arabia Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 83 Key country dynamics
Fig. 84 Kuwait Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 85 Key country dynamics
Fig. 86 Qatar Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Fig. 87 Key country dynamics
Fig. 88 Oman Healthcare Analytical Testing Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
提及公司
同分類最新報告(醫療器材)
常見問題
這份報告可以先索取樣本嗎?
可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算?
報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付?如何付款?
一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們